Product Images Atorvastatin Calcium

This appears to be a chart or graph displaying the cumulative incidence rates (%) of something for two different groups (Atorvastatin and Placebo). The chart seems to have markers at 0.5, 1.0, 1.5, 20, 25, and 3.0, and there is a result of 64 with a p-value of 0.0005. The study appears to have spanned 3.5 years. Without additional information or context, it is not clear what is being measured or evaluated.*

This text represents a graph showing the cumulative hazard percentage over time, with data points at years 1, 2, 3, 4, and 5. There is also a hazard ratio (HR) presented on the graph, with a confidence interval and p-value. The primary endpoint data is also shown for the first four years of follow-up.*

This text is a report of a clinical trial evaluating the efficacy of Atorvastatin in reducing the incidence of major cardiovascular events. The text presents the percentage of subjects experiencing the event, the dosage of Atorvastatin used, and the hazard ratio of the medication. Additionally, the text shows a graph indicating the time to the first major cardiovascular endpoint in years.*

Calcium Tablets USP containing Torvastatin. The package contains 90 tablets with patient information leaflet attached. The package is serialized with a coding area. The GTIN number for this package is 0300935056982. Revision B is from March 2020.*

The text seems to be a label for Calcium Tablets with a request for a pharmacist to dispense them along with the attached patient information leaflet. The label also includes a code (NDC 0093-5059-98) and details about the number of tablets (90). There is also a mention of Atorvastatin, but it is not clear if it is included in the tablets or just referenced for some reason. The rest of the text seems to be random symbols and codes.*

This is the attached patient information leaflet for Torvastatin, a medication that comes in 40mg tablets. It is advised to keep this medication and all others out of the reach of children. The medication is manufactured for Teva Pharmaceuticals USA, Inc. and has a serialization coding area. The rest of the text seems to be random characters and not readable.*

This is a medication information sheet for Atorvastatin tablets USP with a strength of 80mg. It is intended for pharmacists and provides details on dispensing the medication. The sheet includes a National Drug Code (NDC) and Global Trade Identification Number (GTIN). The medication is not intended for children and the sheet reminds users to keep it and all medications out of their reach.*